omniture
3SBIO INC.

Latest News

3SBio and Ascentage Pharma Form Strategic Alliance to Research, Develop and Commercialize Cancer Therapeutics

SHENYANG, China, Feb. 12 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company...

2010-02-12 09:00 723

3SBio and Panacor Bioscience Enter Collaboration and License Agreement to Develop and Commercialize Nephoxil(R) for Hyperphosphatemia

SHENYANG, China, Feb. 8 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company"...

2010-02-08 19:13 1005

3SBio Inc. to Report 2009 Fourth Quarter and Full Year Results on February 11, 2010

SHENYANG, China, Jan. 26 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company...

2010-01-26 13:36 803

3SBio Inc. Applies for SFDA Registrational Trial for Feraheme(TM)

SHENYANG, China, Jan. 8 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology ...

2010-01-08 17:17 621

3SBio Inc. Announces Unaudited Third Quarter 2009 Results

Third quarter revenue grew 35.8% year-over-year to RMB92.6 million (US$13.6 million); Operating inco...

2009-11-13 06:00 724

3SBio Inc. to Report 2009 Third Quarter Earnings on November 12, 2009

SHENYANG, China, Oct. 28 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company...

2009-10-28 01:04 654

3SBio Inc. Announces Results of Annual General Meeting

SHENYANG, China, Oct. 20 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "Company"), ...

2009-10-20 11:37 616

3SBio Inc. to Hold 2009 Annual General Meeting on October 12, 2009

SHENYANG, China, Sept. 7 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX) (“3SBio” or “C...

2009-09-07 08:58 770

3SBio Inc. Announces Unaudited Second Quarter 2009 Results

Second quarter revenue grew 36.8% year-over-year to RMB81.5 million (US$11.9million) Operating ...

2009-08-12 05:00 788

3SBio Inc. to Report 2009 Second Quarter Earnings on August 11, 2009

SHENYANG, China, July 23 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading Chi...

2009-07-23 16:01 653

3SBio Inc. Announces Unaudited First Quarter 2009 Results

First Quarter Revenue Grows 23.7% Year-over-year to RMB68.6 Million (US$10.0 Million); Operating Inc...

2009-05-20 05:00 683

3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor

SHENYANG, China, May 5 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or "the Company")...

2009-05-05 19:30 630

3SBio Inc. to Report 2009 First Quarter Earnings on May 19, 2009

SHENYANG, China, May 4 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based bio...

2009-05-04 19:30 661

3SBio Inc. Announces Unaudited Fourth Quarter and Fiscal Year 2008 Results

Company Exceeds Guidance with 2008 Revenue of RMB243.2 million (US$35.7 million); Full year 2008...

2009-03-12 05:00 692

3SBio Inc. Receives Official Recognition as a ‘High-Tech Enterprise’

SHENYANG, China, March 5 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based b...

2009-03-05 21:30 688

3SBio Inc. to Report 2008 Fourth Quarter and Full Year Earnings on March 11, 2009

SHENYANG, China, Feb. 25 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading China-based b...

2009-02-25 21:00 819

3SBio Inc. Appoints Mr. Bo Tan as Chief Financial Officer

SHENYANG, China, Feb. 9 /PRNewswire-Asia/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnolog...

2009-02-09 21:30 810

3SBio Inc. Files for SFDA Approval for TPIAO Label Extension for the Treatment of ITP

SHENYANG, China, Jan. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (Nasdaq: SSRX), a leading bio...

2009-01-20 21:30 620

3SBio Inc. to Present at the Piper Jaffray 20th Annual Health Care Conference

SHENYANG, China, Nov. 25 /PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX), a leading biotechnology comp...

2008-11-25 05:30 781

3SBio Inc. Announces Third Quarter 2008 Results

SHENYANG, China, Nov. 11 /Xinhua-PRNewswire/ -- 3SBio Inc. (Nasdaq: SSRX) ("3SBio" or the "Compa...

2008-11-11 05:30 859